Work

MA07.05 Survivors from Anti-PD-(L)1 Immunotherapy in NSCLC: Clinical Features, Survival Outcomes and Long-term Toxicities

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.01.186

Authors: M. Hsu, J. Murray, J. Zhang, D. Barasa, M. Turner, P. Forde, D. Ettinger, V. Lam, K. Marrone, B. Levy, C. Hann, J. Brahmer, J. Feliciano, J. Naidoo

Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3136751016

Cites:

Cited by:

Related to: 10